Is Injective Safe?
Risk Grade: B- (34/100)
Injective is rated as moderate risk — some novel mechanisms, generally well-understood.
Moderate risk — purpose-built derivatives chain with thin liquidity and a burn model that amplifies both bull and bear cycles
A Layer 1 blockchain purpose-built for derivatives trading, with a fully on-chain order book and a weekly token burn funded by trading fees. It holds $74M in TVL with $40M in funding. Its C+ grade reflects thin on-chain liquidity making the order book vulnerable to manipulation, plus an untested MEV-resistance mechanism.
TVL
$74M
Mechanisms
8
Interactions
5
Value Grade
B-
Key Risks for Injective Users
The on-chain order book is much thinner than centralized exchanges. A well-funded attacker can manipulate prices to trigger cascading liquidations of leveraged positions
INJ token value depends on weekly token burns funded by trading fees. During bear markets when trading drops, the burns slow down and the scarcity narrative that supports the price collapses
The anti-front-running system uses a novel timing mechanism that has never been tested under real adversarial conditions. If it fails, traders can be systematically front-run
Top Risk Factors
- •On-chain orderbook for derivatives is thin relative to CEX liquidity, making it vulnerable to manipulation and cascading liquidations
- •Burn auction deflationary model depends entirely on sustained dApp fee revenue, which collapsed during prior bear markets
- •MEV resistance via verifiable delay functions is novel and untested under adversarial conditions at scale
Risk Score Breakdown
Injective's highest risk area is Vitality Risk (6/10). Here's how each dimension contributes to the overall 34/100 score:
Read the Full Injective Risk Report
This protocol has 2 collapse scenarios. 1 critical and 1 high-severity interaction risks identified. See the full mechanism classification, interaction matrix, and deep-dive recommendations.
View Full Report →Considering an investment?